A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2018-03-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to confirm efficacy of ASP1941 based on the changes in HbA1c
and to assess its safety in subjects with type 1 diabetes mellitus receiving ASP1941 once
daily in combination with insulin for 24 weeks. This study will also assess the
safety/efficacy of long-term treatment (52 weeks).